Overview
Dr. Srivastava is an Assistant Professor of Clinical Psychiatry in the Division of Substance Use Disorders at Columbia University Medical Center. He received his M.D. from the University of Florida College of Medicine, completed his residency in general psychiatry at Washington University School of Medicine, and clinical fellowship in Addiction Psychiatry/T32 Research fellowship in Substance Use Disorders at Columbia University/NYSPI. His current research interests include using advanced functional imaging techniques to investigate mechanisms of changes protracted abstinence and cognitive control involved in relapse and recovery in alcohol use disorder. He was awarded an NIH K23 Career Development Award in 2024.
Areas of Expertise / Conditions Treated
- Addiction
- Adjustment Disorder
- Adult Psychotherapy
- Alcohol Use Disorders
- Anxiety
- Attention Deficit Hyperactivity Disorder (ADHD)
- Bipolar Disorder
- Depression
- Generalized Anxiety Disorder
- Insomnia
- Mental Health
- Mood Disorders
- Obsessive Compulsive Disorder (OCD)
- Opioid Use Disorders
- Panic Disorder
- Psychopharmacology
- Psychosis
- Schizophrenia
- Social Anxiety Disorder
- Substance Use
Academic Appointments
- Assistant Professor of Clinical Psychiatry
Gender
- Male
Schedule an Appointment
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Affinity Health Plan
- Beacon Health - Behavioral Health
UnitedHealthcare
- Behavioral Health (Columbia University Employee Plan)
Credentials & Experience
Education & Training
- MD, University of Florida, College of Medicine
- Internship: Washington University School of Medicine/Barnes Jewish Hospital
- Residency: Washington University School of Medicine/Barnes Jewish Hospital
- Fellowship: Columbia University Irving Medical Center/New York State Psychiatric Institute
Board Certifications
- Psychiatry
Research
Grants
2024-2029
Neural mechanisms of anxiety during early and protracted abstinence in alcohol use disorder
NIH/NIAAA K23AA030355
Selected Publications
Naqvi NH, Srivastava AB, Sanchez-Peña J, Lee JK, Drysdale AT, Mariani JJ, Ochsner KN, Morgenstern J, Patel GH, Levin FR. Neural correlates of drinking reduction during a clinical trial of cognitive behavioral therapy for alcohol use disorder. Alcohol Clin Exp Res (Hoboken). 2024 Feb;48(2):260-272. doi: 10.1111/acer.15259. Epub 2024 Jan 15. PMID: 38225187; PMCID: PMC11015435. https://pubmed.ncbi.nlm.nih.gov/38225187/
Srivastava AB, Sanchez-Peña J, Levin FR, Mariani JJ, Patel GH, Naqvi NH. Drinking reduction during cognitive behavioral therapy for alcohol use disorder is associated with a reduction in anterior insula-bed nucleus of the stria terminalis resting-state functional connectivity. Alcohol Clin Exp Res. 2021 Aug;45(8):1596-1606. doi: 10.1111/acer.14661. Epub 2021 Aug 2. Erratum in: Alcohol Clin Exp Res (Hoboken). 2023 Jul;47(7):1423-1424. doi: 10.1111/acer.14767. PMID: 34342012; PMCID: PMC8429084. https://pubmed.ncbi.nlm.nih.gov/34342012/
Srivastava AB, Mariani JJ, Levin FR. New directions in the treatment of opioid withdrawal. Lancet. 2020 Jun 20;395(10241):1938-1948. doi: 10.1016/S0140-6736(20)30852-7. PMID: 32563380; PMCID: PMC7385662. https://pubmed.ncbi.nlm.nih.gov/32563380/
Sylvester CM, Yu Q, Srivastava AB, Marek S, Zheng A, Alexopoulos D, Smyser CD, Shimony JS, Ortega M, Dierker DL, Patel GH, Nelson SM, Gilmore AW, McDermott KB, Berg JJ, Drysdale AT, Perino MT, Snyder AZ, Raut RV, Laumann TO, Gordon EM, Barch DM, Rogers CE, Greene DJ, Raichle ME, Dosenbach NUF. Individual-specific functional connectivity of the amygdala: A substrate for precision psychiatry. Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3808-3818. doi: 10.1073/pnas.1910842117. Epub 2020 Feb 3. PMID: 32015137; PMCID: PMC7035483. https://pubmed.ncbi.nlm.nih.gov/32015137/